Buy, Sell Or Hold: Swan Energy, Senco Gold, Piramal Pharma, Tata Power, — Ask Profit

Should you buy shares of Swan Energy Ltd. at the current market price? Is Senco Gold Ltd. a good choice from a long-term perspective? Should you keep holding shares of SBI Cards and Payment Services Ltd.? Is it the right time to exit Piramal Pharma Ltd. and book profits?

Vikas Jain, head of research of Reliance Securities, answered these investor queries and more on NDTV Profit's Ask Profit show.

Vikas: Exit

• The company has experienced a significant selloff, reaching multi-year lows.

• The stock may fall to approximately Rs 385-370, indicating a 10-12% decline from current levels.

• It might be ideal to exit now or during a rally.

Vikas: Sock witnessed selloff

• The stock has experienced a sharp decline along with significant selloff.

• Further decline to Rs 285-300 levels cannot be ruled out.

• These levels would be an ideal entry point for investment as they could mark the first breakout zone.

Vikas: Stay invested

• The stock had been an underperformer for about two and a half years, but it has since recovered well and is now outperforming the broader markets.

• The counter has crossed multiple bands of higher top formation structures.

• The first resistance band is at Rs 960-965. If this is crossed, it can move towards Rs 1,030.

Vikas: Stock seen corrective actions.

• The pharma sector experienced significant corrective action throughout the week.

• The stock is close to its 200-day moving average and has seen corrective action below this average.

• A bounce is expected near Rs 205-210, which should be considered the exit range.

Vikas: Stay invested

• Continue to stay invested as Tata Power is benefiting from multiple business inflows.

• The stock is near its 100-week support average, observed over the last four to five weeks.

• The risk-reward ratio remains favorable at current levels.

• Investors can remain invested and expect the stock to reach Rs 410-420 in the next six to nine months.

Vikas: Exit

• It's advisable to exit the stock due to its recent involvement in various GST-related issues.

• The stock has significantly underperformed over the last six months to a year.

• Investing in another stock may help recover the losses.

Vikas: Stock looks promising

• The stock's structure appears promising, though some profit booking has been observed.

• Corrective actions should not be ignored.

• The pharma sector as a whole is under pressure.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.